Board of Directors

Carter H. Eckert, Former Chairman and CEO, IMPATH, Inc.

Carter H. Eckert has been a member of our board of directors since December 2005. Mr. Eckert served as chairman of AlgoRx’s board of directors prior to the merger of AlgoRx and Anesiva. From February 2003 to March 2004, Mr. Eckert was the chairman of the board of directors and chief executive officer of IMPATH Inc., a cancer information company. From 1995 through March 2001, Mr. Eckert served as President of Knoll Pharmaceutical Company and as President of the Americas for Knoll’s parent company, BASF Pharma. During that period, Mr. Eckert also was a member of BASF Pharma’s Pharmaceutical Board, where he was responsible for global therapeutic franchises and corporate transactions. Prior to joining Knoll and BASF Pharma in 1995, Mr. Eckert was President and Chief Executive Officer of Boots Pharmaceuticals, Inc. where he was responsible for North American operations. Mr. Eckert joined Boots Pharmaceuticals in 1985 as Executive Vice President and Chief Operating Officer after more than a decade at Baxter Travenol Laboratories, where he served as President of the Pharmaceutical Products Division. Mr. Eckert serves on the board of directors of Andrx Corporation and is a trustee of Caldwell College. Mr. Eckert received a B.S. in Chemical Engineering from the Illinois Institute of Technology and an M.B.A. from Northwestern University.